A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Telesis Bio Inc’s current trading price is -88.25% away from its 52-week high, while its distance from the 52-week low is 22.31%. The stock’s price range for this time frame has been between $3.03 and $31.50. The trading volume of the company’s shares in the Healthcare reached around 0.61 million for the day, which was evidently higher than the average daily volume of 32049.0 over the last three months.
The stock market performance of Telesis Bio Inc has been fairly unsteady. Over the last year, the company’s stock hit its highest at $31.50 on 07/12/23, while the lowest price during the same time frame was $3.03, recorded on 06/11/24.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
How Financial Performance Impacts Market Capitalization
Telesis Bio Inc (TBIO) has experienced a quarterly decline of -51.80% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 6.18M and boasts a workforce of 147 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 6.21, with a change in price of -1.97. Similarly, Telesis Bio Inc recorded 51,346 in trading volume during the last 100 days, posting a change of -34.79%.
How TBIO’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for TBIO stands at 1.67. Similarly, the long-term debt-to-equity ratio is also 1.62.
TBIO Stock Stochastic Average
Telesis Bio Inc’s raw stochastic average for the past 50 days is currently at 15.83%. This represents a fall from the raw stochastic average of the last 20 days, which was recorded at 22.45%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 37.79% and 38.18%, respectively.
TBIO Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. The metric has seen a significant loss of -48.48% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -44.94%. Over the past 30 days, the price of TBIO has fallen by 22.11%. And in the last five days, it has fallen by -2.12%.
